Vivani Medical Statistics
Total Valuation
Vivani Medical has a market cap or net worth of $101.16 million. The enterprise value is $90.82 million.
| Market Cap | 101.16M |
| Enterprise Value | 90.82M |
Important Dates
The last earnings date was Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Vivani Medical has 54.98 million shares outstanding. The number of shares has increased by 2.85% in one year.
| Shares Outstanding | 54.98M |
| Shares Change (YoY) | +2.85% |
| Shares Change (QoQ) | +2.07% |
| Owned by Insiders (%) | 45.54% |
| Owned by Institutions (%) | 6.14% |
| Float | 30.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.53 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.13, with a Debt / Equity ratio of 0.71.
| Current Ratio | 5.13 |
| Quick Ratio | n/a |
| Debt / Equity | 0.71 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -93.90% and return on invested capital (ROIC) is -54.17%.
| Return on Equity (ROE) | -93.90% |
| Return on Assets (ROA) | -47.80% |
| Return on Capital (ROIC) | -54.17% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$576,659 |
| Employee Count | 44 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.31% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | +34.31% |
| 50-Day Moving Average | 1.88 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 50.71 |
| Average Volume (30 Days) | 3,170,656 |
Short Selling Information
The latest short interest is 698,008, so 1.27% of the outstanding shares have been sold short.
| Short Interest | 698,008 |
| Short Previous Month | 589,062 |
| Short % of Shares Out | 1.27% |
| Short % of Float | 2.28% |
| Short Ratio (days to cover) | 3.93 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.59M |
| Pretax Income | -25.37M |
| Net Income | -25.37M |
| EBITDA | -23.98M |
| EBIT | -25.37M |
| Earnings Per Share (EPS) | -$0.49 |
Balance Sheet
The company has $30.99 million in cash and $20.37 million in debt, giving a net cash position of $10.61 million or $0.19 per share.
| Cash & Cash Equivalents | 30.99M |
| Total Debt | 20.37M |
| Net Cash | 10.61M |
| Net Cash Per Share | $0.19 |
| Equity / Book Value | 28.71M |
| Book Value Per Share | 0.52 |
| Working Capital | 25.36M |
Cash Flow
In the last 12 months, operating cash flow was -$21.25 million and capital expenditures -$1.03 million, giving a free cash flow of -$22.28 million.
| Operating Cash Flow | -21.25M |
| Capital Expenditures | -1.03M |
| Free Cash Flow | -22.28M |
| FCF Per Share | -$0.43 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Vivani Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.85% |
| Shareholder Yield | -2.85% |
| Earnings Yield | -25.01% |
| FCF Yield | -21.96% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 19, 2022. It was a reverse split with a ratio of 1:3.
| Last Split Date | Aug 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |